JP7680824B2 - 新規ペプチド及びその新規ペプチドを活性成分として含む眼疾患の治療のための医薬組成物 - Google Patents

新規ペプチド及びその新規ペプチドを活性成分として含む眼疾患の治療のための医薬組成物 Download PDF

Info

Publication number
JP7680824B2
JP7680824B2 JP2019563617A JP2019563617A JP7680824B2 JP 7680824 B2 JP7680824 B2 JP 7680824B2 JP 2019563617 A JP2019563617 A JP 2019563617A JP 2019563617 A JP2019563617 A JP 2019563617A JP 7680824 B2 JP7680824 B2 JP 7680824B2
Authority
JP
Japan
Prior art keywords
gly
leu
ala
pro
gln
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Active
Application number
JP2019563617A
Other languages
English (en)
Japanese (ja)
Other versions
JP2020520372A (ja
JP2020520372A5 (https=
Inventor
ベク，テゴン
キム，テク－ス
リム，デ－ソン
グ，ドゥク－ヨン
Original Assignee
ユーユー ファーマ，インコーポレーテッド
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by ユーユー ファーマ，インコーポレーテッド filed Critical ユーユー ファーマ，インコーポレーテッド
Publication of JP2020520372A publication Critical patent/JP2020520372A/ja
Publication of JP2020520372A5 publication Critical patent/JP2020520372A5/ja
Priority to JP2023061251A priority Critical patent/JP7775250B2/ja
Application granted granted Critical
Publication of JP7680824B2 publication Critical patent/JP7680824B2/ja
Active legal-status Critical Current
Anticipated expiration legal-status Critical

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/04—Peptides having up to 20 amino acids in a fully defined sequence; Derivatives thereof
    • A61K38/08—Peptides having 5 to 11 amino acids
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K7/00—Peptides having 5 to 20 amino acids in a fully defined sequence; Derivatives thereof
    • C07K7/02—Linear peptides containing at least one abnormal peptide link
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P27/00—Drugs for disorders of the senses
    • A61P27/02—Ophthalmic agents
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K7/00—Peptides having 5 to 20 amino acids in a fully defined sequence; Derivatives thereof
    • C07K7/04—Linear peptides containing only normal peptide links
    • C07K7/06—Linear peptides containing only normal peptide links having 5 to 11 amino acids
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Organic Chemistry (AREA)
  • Medicinal Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Engineering & Computer Science (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Animal Behavior & Ethology (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Genetics & Genomics (AREA)
  • Molecular Biology (AREA)
  • Biophysics (AREA)
  • Biochemistry (AREA)
  • Immunology (AREA)
  • Epidemiology (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Ophthalmology & Optometry (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Peptides Or Proteins (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
JP2019563617A 2017-05-17 2018-05-17 新規ペプチド及びその新規ペプチドを活性成分として含む眼疾患の治療のための医薬組成物 Active JP7680824B2 (ja)

Priority Applications (1)

Application Number Priority Date Filing Date Title
JP2023061251A JP7775250B2 (ja) 2017-05-17 2023-04-05 新規ペプチド及びその新規ペプチドを活性成分として含む眼疾患の治療のための医薬組成物

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
KR20170061250 2017-05-17
KR10-2017-0061250 2017-05-17
PCT/KR2018/005673 WO2018225961A1 (ko) 2017-05-17 2018-05-17 신규한 펩타이드 및 이를 유효성분으로 포함하는 안구질환 치료용 약학 조성물

Related Child Applications (1)

Application Number Title Priority Date Filing Date
JP2023061251A Division JP7775250B2 (ja) 2017-05-17 2023-04-05 新規ペプチド及びその新規ペプチドを活性成分として含む眼疾患の治療のための医薬組成物

Publications (3)

Publication Number Publication Date
JP2020520372A JP2020520372A (ja) 2020-07-09
JP2020520372A5 JP2020520372A5 (https=) 2021-07-26
JP7680824B2 true JP7680824B2 (ja) 2025-05-21

Family

ID=64566301

Family Applications (2)

Application Number Title Priority Date Filing Date
JP2019563617A Active JP7680824B2 (ja) 2017-05-17 2018-05-17 新規ペプチド及びその新規ペプチドを活性成分として含む眼疾患の治療のための医薬組成物
JP2023061251A Active JP7775250B2 (ja) 2017-05-17 2023-04-05 新規ペプチド及びその新規ペプチドを活性成分として含む眼疾患の治療のための医薬組成物

Family Applications After (1)

Application Number Title Priority Date Filing Date
JP2023061251A Active JP7775250B2 (ja) 2017-05-17 2023-04-05 新規ペプチド及びその新規ペプチドを活性成分として含む眼疾患の治療のための医薬組成物

Country Status (13)

Country Link
US (1) US12037415B2 (https=)
EP (1) EP3643723B1 (https=)
JP (2) JP7680824B2 (https=)
KR (2) KR102287226B1 (https=)
CN (1) CN110945012A (https=)
AU (1) AU2018281617B2 (https=)
BR (1) BR112019024040A2 (https=)
CA (1) CA3063842A1 (https=)
ES (1) ES2982308T3 (https=)
MX (1) MX2019013799A (https=)
RU (1) RU2766160C2 (https=)
SG (1) SG11201912110YA (https=)
WO (1) WO2018225961A1 (https=)

Families Citing this family (10)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
KR102287226B1 (ko) 2017-05-17 2021-08-11 주식회사 유유제약 신규한 펩타이드 및 이를 유효성분으로 포함하는 안구질환 치료용 약학 조성물
US11613558B2 (en) 2018-11-14 2023-03-28 Yuyu Pharma, Inc. Peptides and pharmaceutical compositions for treating eye diseases
TWI865470B (zh) * 2018-11-14 2024-12-11 南韓商柳柳製藥股份有限公司 治療眼睛疾病之肽及醫藥組合物
JP7576048B2 (ja) * 2019-05-21 2024-10-30 アイバイオ コリア 新規なペプチド化合物またはその薬学的に許容される塩
KR20210104460A (ko) * 2020-02-17 2021-08-25 주식회사 아이바이오코리아 고체상 합성법을 이용한 펩타이드의 제조 방법
EP4114430A4 (en) * 2020-03-05 2025-05-14 YUYU Pharma, Inc. TREATMENT OF INFLAMMATORY DISEASES WITH PEPTIDES AND PHARMACEUTICAL COMPOSITIONS
KR102593936B1 (ko) * 2021-12-13 2023-10-27 주식회사 아이바이오코리아 신규한 펩타이드를 포함하는 황반변성의 치료용 조성물
AU2022412618B2 (en) * 2021-12-13 2026-02-19 Eyebiokorea, Inc. Composition for treating macular degeneration comprising novel peptide
KR102587729B1 (ko) * 2023-02-27 2023-10-12 주식회사 아이바이오코리아 펩타이드를 포함하는 당뇨망막병증의 치료용 조성물
KR102673860B1 (ko) * 2023-08-10 2024-06-12 (주)케어젠 안구 건조증의 개선 활성을 갖는 펩타이드 및 이의 용도

Citations (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
KR101795653B1 (ko) 2016-05-19 2017-11-09 인제대학교 산학협력단 콜라겐 타입 ii 펩타이드-아플리버셉트의 키메라 단백질을 유효성분으로 함유하는 혈관신생 억제용 조성물
JP2019519597A (ja) 2016-04-08 2019-07-11 アイバイオ コリアＥｙｅｂｉｏ Ｋｏｒｅａ 軟骨細胞の細胞外基質由来ペプチド

Family Cites Families (19)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6037135A (en) * 1992-08-07 2000-03-14 Epimmune Inc. Methods for making HLA binding peptides and their uses
WO2007117444A2 (en) * 2006-03-31 2007-10-18 Yinghe Hu Protein detection by aptamers
US10611818B2 (en) 2007-09-27 2020-04-07 Agilent Technologies, Inc. MHC multimers in tuberculosis diagnostics, vaccine and therapeutics
US20090131303A1 (en) * 2007-11-16 2009-05-21 Bor-Shyue Hong Methods and compositions for treating dry eye
JP4490498B2 (ja) 2008-09-30 2010-06-23 新田ゼラチン株式会社 疾病抑制剤
CA2836946C (en) * 2011-05-27 2017-08-01 Allergan, Inc. A crystalline form of cyclosporine a, methods of preparation, and methods for use thereof
MX2014006399A (es) * 2011-11-30 2015-04-10 Xigen Inflammation Ltd Uso de inhibidores de peptidos con celulas permeables de la via para transduccion de señal de jnk para el tratamiento de la queratoconjuntivitis seca.
KR101438744B1 (ko) * 2012-08-02 2014-09-15 전남대학교산학협력단 아디포넥틴을 유효성분으로 포함하는 안구건조증 또는 염증성 안구표면 질환의 예방 또는 치료용 조성물
KR101555296B1 (ko) 2013-12-10 2015-09-23 인제대학교 산학협력단 연골세포 유래 세포외 기질을 유효성분으로 함유하는 건성안 예방 또는 치료용 약학조성물
KR101948156B1 (ko) 2013-12-10 2019-02-14 인제대학교 산학협력단 알칼리 화상을 이용한 각막 혼탁증 동물모델 및 각막 혼탁증 예방 또는 치료용 약학조성물
KR101721059B1 (ko) 2014-12-26 2017-03-30 주식회사 아이바이오코리아 안구 표면 질환 예방 또는 치료용 약학조성물
KR101690539B1 (ko) 2015-07-30 2016-12-29 주식회사 아이바이오코리아 건성안 예방 또는 치료용 약학조성물
TWI675851B (zh) 2015-12-14 2019-11-01 台灣基督長老教會馬偕醫療財團法人馬偕紀念醫院 短合成胜肽及其用途
KR101798183B1 (ko) * 2016-04-08 2017-11-15 주식회사 아이바이오코리아 건성안 예방 또는 치료용 약학조성물
KR20180074928A (ko) 2016-12-26 2018-07-04 주식회사 아이바이오코리아 건성안 예방 또는 치료용 동물 의약품 조성물
KR102287226B1 (ko) 2017-05-17 2021-08-11 주식회사 유유제약 신규한 펩타이드 및 이를 유효성분으로 포함하는 안구질환 치료용 약학 조성물
TWI865470B (zh) * 2018-11-14 2024-12-11 南韓商柳柳製藥股份有限公司 治療眼睛疾病之肽及醫藥組合物
US11613558B2 (en) 2018-11-14 2023-03-28 Yuyu Pharma, Inc. Peptides and pharmaceutical compositions for treating eye diseases
EP4114430A4 (en) * 2020-03-05 2025-05-14 YUYU Pharma, Inc. TREATMENT OF INFLAMMATORY DISEASES WITH PEPTIDES AND PHARMACEUTICAL COMPOSITIONS

Patent Citations (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP2019519597A (ja) 2016-04-08 2019-07-11 アイバイオ コリアＥｙｅｂｉｏ Ｋｏｒｅａ 軟骨細胞の細胞外基質由来ペプチド
KR101795653B1 (ko) 2016-05-19 2017-11-09 인제대학교 산학협력단 콜라겐 타입 ii 펩타이드-아플리버셉트의 키메라 단백질을 유효성분으로 함유하는 혈관신생 억제용 조성물

Also Published As

Publication number Publication date
AU2018281617B2 (en) 2022-06-30
SG11201912110YA (en) 2020-01-30
EP3643723B1 (en) 2024-05-15
RU2019141646A3 (https=) 2021-07-28
ES2982308T3 (es) 2024-10-15
JP2023098936A (ja) 2023-07-11
RU2019141646A (ru) 2021-06-17
JP2020520372A (ja) 2020-07-09
CN110945012A (zh) 2020-03-31
US12037415B2 (en) 2024-07-16
BR112019024040A2 (pt) 2020-09-24
US20210024577A1 (en) 2021-01-28
RU2766160C2 (ru) 2022-02-08
EP3643723C0 (en) 2024-05-15
MX2019013799A (es) 2020-08-13
KR102498428B1 (ko) 2023-02-20
EP3643723A1 (en) 2020-04-29
CA3063842A1 (en) 2019-12-09
AU2018281617A1 (en) 2019-12-05
KR20210097670A (ko) 2021-08-09
EP3643723A4 (en) 2021-03-31
WO2018225961A1 (ko) 2018-12-13
KR102287226B1 (ko) 2021-08-11
KR20180126406A (ko) 2018-11-27
JP7775250B2 (ja) 2025-11-25

Similar Documents

Publication Publication Date Title
JP7775250B2 (ja) 新規ペプチド及びその新規ペプチドを活性成分として含む眼疾患の治療のための医薬組成物
CN103435570B (zh) 治疗剂的药代动力学特性调节剂
JP7522732B2 (ja) 眼疾患治療用のペプチド及び医薬組成物
WO2024088409A1 (zh) 一种含氮杂环化合物、其药学上可接受的盐及其制备方法与应用
CN111333648B (zh) 8-取代的芳香环乙烯基黄嘌呤衍生物及其用途
CA2687817A1 (en) Heteroaryl substituted thiazoles
WO2020016434A1 (en) Cyclic inhibitors of hepatitis b virus
CN110981876A (zh) 8-取代的苯乙烯基黄嘌呤衍生物及其用途
WO2022156758A1 (zh) 新型酰胺吡咯类化合物及其在药物中的用途
WO2021088839A1 (zh) 咪唑烷酮类化合物及其制备方法与应用
WO2021088845A1 (zh) 咪唑烷酮类化合物及其制备方法与应用
CN111018856B (zh) 8-取代的苯乙烯基黄嘌呤衍生物及其用途
CA3119921C (en) Peptides and pharmaceutical compositions for treating eye diseases
HK40017864A (en) Novel peptide and pharmaceutical composition for treatment of eye diseases comprising same novel peptide as active ingredient
RU2819399C2 (ru) Пептиды и фармацевтические композиции для лечения глазных болезней
CN109734712A (zh) 芳基或杂芳基取代的吡咯烷酰胺衍生物及其用途
JP2010515690A (ja) 医薬品の多形及び溶媒和物、並びに製造方法
HK40061089B (zh) 用於治疗眼病的肽和药物组合物
HK40061089A (en) Peptides and pharmaceutical compositions for treating eye diseases
CN111072663A (zh) 8-取代的苯乙烯基黄嘌呤衍生物及其用途
NZ739511B2 (en) Pyrazole pyrimidine derivative and uses thereof

Legal Events

Date Code Title Description
A521 Request for written amendment filed

Free format text: JAPANESE INTERMEDIATE CODE: A821

Effective date: 20200129

RD01 Notification of change of attorney

Free format text: JAPANESE INTERMEDIATE CODE: A7426

Effective date: 20200129

A521 Request for written amendment filed

Free format text: JAPANESE INTERMEDIATE CODE: A523

Effective date: 20210513

A621 Written request for application examination

Free format text: JAPANESE INTERMEDIATE CODE: A621

Effective date: 20210513

A131 Notification of reasons for refusal

Free format text: JAPANESE INTERMEDIATE CODE: A131

Effective date: 20220531

A521 Request for written amendment filed

Free format text: JAPANESE INTERMEDIATE CODE: A523

Effective date: 20220830

A521 Request for written amendment filed

Free format text: JAPANESE INTERMEDIATE CODE: A821

Effective date: 20220830

A02 Decision of refusal

Free format text: JAPANESE INTERMEDIATE CODE: A02

Effective date: 20221206

A521 Request for written amendment filed

Free format text: JAPANESE INTERMEDIATE CODE: A523

Effective date: 20230405

C60 Trial request (containing other claim documents, opposition documents)

Free format text: JAPANESE INTERMEDIATE CODE: C60

Effective date: 20230405

A911 Transfer to examiner for re-examination before appeal (zenchi)

Free format text: JAPANESE INTERMEDIATE CODE: A911

Effective date: 20230412

C21 Notice of transfer of a case for reconsideration by examiners before appeal proceedings

Free format text: JAPANESE INTERMEDIATE CODE: C21

Effective date: 20230418

A912 Re-examination (zenchi) completed and case transferred to appeal board

Free format text: JAPANESE INTERMEDIATE CODE: A912

Effective date: 20230616

A521 Request for written amendment filed

Free format text: JAPANESE INTERMEDIATE CODE: A523

Effective date: 20250219

A61 First payment of annual fees (during grant procedure)

Free format text: JAPANESE INTERMEDIATE CODE: A61

Effective date: 20250509

R150 Certificate of patent or registration of utility model

Ref document number: 7680824

Country of ref document: JP

Free format text: JAPANESE INTERMEDIATE CODE: R150